775 related articles for article (PubMed ID: 15753206)
1. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
Setoguchi R; Hori S; Takahashi T; Sakaguchi S
J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
[TBL] [Abstract][Full Text] [Related]
3. The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis.
Laurie KL; Van Driel IR; Gleeson PA
Immunol Cell Biol; 2002 Dec; 80(6):567-73. PubMed ID: 12406391
[TBL] [Abstract][Full Text] [Related]
4. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.
Zelenay S; Lopes-Carvalho T; Caramalho I; Moraes-Fontes MF; Rebelo M; Demengeot J
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4091-6. PubMed ID: 15753306
[TBL] [Abstract][Full Text] [Related]
5. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.
Suri-Payer E; Cantor H
J Autoimmun; 2001 Mar; 16(2):115-23. PubMed ID: 11247637
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
7. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M
J Immunol; 1995 Aug; 155(3):1151-64. PubMed ID: 7636184
[TBL] [Abstract][Full Text] [Related]
8. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
[TBL] [Abstract][Full Text] [Related]
9. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells.
Ono M; Shimizu J; Miyachi Y; Sakaguchi S
J Immunol; 2006 Apr; 176(8):4748-56. PubMed ID: 16585568
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
11. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
12. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.
Liang S; Alard P; Zhao Y; Parnell S; Clark SL; Kosiewicz MM
J Exp Med; 2005 Jan; 201(1):127-37. PubMed ID: 15630140
[TBL] [Abstract][Full Text] [Related]
13. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.
Pop SM; Wong CP; Culton DA; Clarke SH; Tisch R
J Exp Med; 2005 Apr; 201(8):1333-46. PubMed ID: 15837817
[TBL] [Abstract][Full Text] [Related]
14. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
[TBL] [Abstract][Full Text] [Related]
15. B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis.
Yu S; Maiti PK; Dyson M; Jain R; Braley-Mullen H
J Exp Med; 2006 Feb; 203(2):349-58. PubMed ID: 16446379
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo.
Zwar TD; Read S; van Driel IR; Gleeson PA
J Immunol; 2006 Feb; 176(3):1609-17. PubMed ID: 16424190
[TBL] [Abstract][Full Text] [Related]
17. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
19. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.
Zheng SG; Wang J; Wang P; Gray JD; Horwitz DA
J Immunol; 2007 Feb; 178(4):2018-27. PubMed ID: 17277105
[TBL] [Abstract][Full Text] [Related]
20. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
Curotto de Lafaille MA; Lino AC; Kutchukhidze N; Lafaille JJ
J Immunol; 2004 Dec; 173(12):7259-68. PubMed ID: 15585848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
